- Home
- DNUT vs CRMD Comparison
DNUT vs CRMD Comparison
Compare DNUT & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNUT | CRMD |
|---|---|---|
| Founded | 1937 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 672.4M | 626.0M |
| IPO Year | 2021 | 2009 |
Fundamental Metrics
Financial Performance| Metric | DNUT | CRMD |
|---|---|---|
| Price | $3.53 | $8.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $4.15 | ★ $14.83 |
| AVG Volume (30 Days) | ★ 2.9M | 1.5M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $1,522,616,000.00 | $311,709,000.00 |
| Revenue This Year | $0.55 | $0.30 |
| Revenue Next Year | $3.59 | N/A |
| P/E Ratio | ★ N/A | $20.35 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $2.88 | $6.13 |
| 52 Week High | $5.73 | $14.96 |
Technical Indicators
Market Signals| Indicator | DNUT | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 57.99 |
| Support Level | $3.13 | $8.09 |
| Resistance Level | $3.66 | $9.03 |
| Average True Range (ATR) | 0.22 | 0.39 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 10.34 | 80.19 |
Price Performance
Historical ComparisonAbout DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.